WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 11'3801 Infant (under 12 months) mortality rate: 172
GDP / capita (US$): 23'2061 Child (under 5 years) mortality rate: 192

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 16'441  16'271  16'098  15'921  15'744  14'576  16'172  14'519 
Births 337  340  342  343  340  234  375  356 
Surviving infants 329  332  334  334  331  225  355  333 
Pop. less than 5 years 1'658  1'665  1'641  1'571  1'518  1'091  1'837  1'674 
Pop. less than 15 years 4'237  4'154  4'066  3'966  3'890  4'036  5'097  4'715 
Female 15-49 years 4'439  4'437  4'435  4'437  4'418  4'040  4'052  3'716 

Number of reported case

(Click for retrospective incidence data for Kazakhstan)
Diphtheria 13  28 
Japanese encephalitis
Measles 73  55  127  245  273 
Mumps 38  67  51  82  131  3'236 
Pertussis 14  43  66  35  39  87  395 
Polio*
Rubella 36  13  44  622  14'989 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kazakhstan)
Vaccine year result method % card seen                                                
BCG 2009  100  MICS   66  95  95  96  96  96  98 
DTP1 2009  99  MICS   66  99  99  99  99  99  97 
DTP3 2009  97  MICS   66  98  100  99  99  98  97 
HepB_BD          95  96  96  96  97  98 
HepB3 2009  70  MICS   66  99  95  99  99  99  100 
Hib3          98  97  95  96  97 
JapEnc         
MCV 2009  94  MICS   66  100  96  100  99  99  99 
MCV2          99  97  99  100  99  99* 
PCV1          62  51 
PCV3          52  39 
Pol3 2009  88  MICS   66  98  99  99  98  99  97 
Rota1         
Rota_last         
Rubella1          100  100  99  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kazakhstan)
BCG 95  95  96  96  96  98 
DTP1 99  99  99  99  98  98 
DTP3 98  99  99  99  98  97 
HepB3 99  95  99  99  99  99 
HepB_BD 95  96  96  96  97  98 
Hib3 98  97  95  96  97 
MCV 99  96  99  99  99  99 
MCV2 99  97  99  99  99  98 
PCV3 52  37 
Pol3 98  98  99  98  99  96 
Rota_last

Number of districts in the country 204  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; 6 years; Yes
DT 6 years; Yes
DTaPHibHepIPV 2, 4 months; Yes
DTaPHibIPV 3, 18 months; Yes
Dip No
HPV 11 years; Yes
HepA 2 years; No
HepB birth; Yes
Influenza 6 months; 15 years; No
MMR 1, 6 year; Yes
MenACWY 15 years; travelers
OPV 12 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes persons with animal bites
TBE Yes high risk groups
TT No
Td 16 years; Yes every 10 years
Typhoid Yes risk groups

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes    No  No  No  No 
What years does the MYP cover? number   2012-2015           
Nº of districts with microplans that include activities to raise immunization coverage number 204    205  204  204  204   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No       

System performance

Total Nº districts in country number 204  204  205  204  204  204  203 
Nº districts with DTP3 coverage >=80% number 204    205  204  204  204 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 204    205  204  204  203   
% of districts with MCV1 coverage >=95% From 0 to 100% 100    100  100  100  100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%              

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.